Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Early-Stage Lung Cancer in Sputum Using Flow Cytometry and an Automated Analysis Pipeline

NCT07168993 is registered in ClinicalTrials.gov with bioAffinity Technologies Inc. as lead sponsor.

NCT NCT07168993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07168993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Early-Stage Lung Cancer in Sputum Using Flow Cytometry and an Automated Analysis Pipeline
Lead sponsor
bioAffinity Technologies Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
February 25, 2026
Completion date
July 1, 2029
Enrollment
2,063 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (diagnosis)